MedTrace Logo

Epidemiologic Intelligence Network (EpI-Net) to Promote COVID-19 Testing

NCT04910542 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3301

Last updated 2025-03-17

No results posted yet for this study

Summary

The investigators propose a mixed-methods intervention design to evaluate the acceptability of epidemic intelligence (EpI-Net) intervention using Community Engagement (CE) principles to promote COVID-19 testing and prevention practices in socially vulnerable communities in PR. The team hypothesizes that the integration of lay community leaders, trained in the use of COVID-19 prevention technology tools (EpI-Net), will result in increased COVID-19 testing uptake and prevention practices among the targeted socially and epidemiologically vulnerable communities in Puerto Rico.

Conditions

  • Covid19

Interventions

OTHER

Epi-Net Intervention

The Epidemiological Intelligence Network Intervention (Epi-Net) is a group of field epidemiology tools for test, trace and isolate using a community-based approach. The overall goal of Epi-Net is to increase uptake of COVID-19 testing and prevention practices among socially vulnerable communities in Puerto Rico. The intervention intends to impact COVID-19 risk perception, decrease COVID-19 testing barriers, increase testing uptake and increase health promotion strategies.

Sponsors & Collaborators

  • Duke University

    collaborator OTHER

  • Harvard School of Public Health (HSPH)

    collaborator OTHER

  • Ponce Medical School Foundation, Inc.

    lead INDUSTRY

Principal Investigators

  • Eida M Castro, PsyD · Ponce Medical School Foundation

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-09
Primary Completion
2023-05-31
Completion
2023-05-31

Countries

  • Puerto Rico

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04910542 on ClinicalTrials.gov